AbInitio Bio is a company headquartered in the United States.
AbInitio Bio develops foundation AI models for biomanufacturing that are validated against wet lab data; its first model, Echo, predicts manufacturing outcomes and can be adapted by pharmaceutical companies and CDMOs to accelerate process decisions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.